|
SUPT16H expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.51569999998313E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.426200E-04 |
| Normal-vs-Stage2 |
4.78699999639787E-08 |
| Normal-vs-Stage3 |
2.73409999973495E-07 |
| Normal-vs-Stage4 |
5.807000E-04 |
| Stage1-vs-Stage2 |
1.535460E-03 |
| Stage1-vs-Stage3 |
1.859930E-03 |
| Stage1-vs-Stage4 |
2.004200E-01 |
| Stage2-vs-Stage3 |
5.112600E-01 |
| Stage2-vs-Stage4 |
2.305000E-01 |
| Stage3-vs-Stage4 |
4.741200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.98989999999899E-06 |
| Normal-vs-AfricanAmerican |
7.381200E-03 |
| Normal-vs-Asian |
4.420000E-01 |
| Caucasian-vs-AfricanAmerican |
2.866200E-01 |
| Caucasian-vs-Asian |
3.334200E-01 |
| AfricanAmerican-vs-Asian |
5.715400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.3459000000049E-06 |
| Normal-vs-Female |
2.203400E-04 |
| Male-vs-Female |
4.075700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.695900E-03 |
| Normal-vs-Age(41-60Yrs) |
6.15840000000034E-05 |
| Normal-vs-Age(61-80Yrs) |
1.29859999975501E-07 |
| Normal-vs-Age(81-100Yrs) |
3.228800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.634200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.916800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.160000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.841200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.619600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.886400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.634600E-01 |
| Normal-vs-Grade 2 |
2.566600E-04 |
| Normal-vs-Grade 3 |
2.43800000188088E-08 |
| Normal-vs-Grade 4 |
7.043900E-04 |
| Grade 1-vs-Grade 2 |
4.239800E-02 |
| Grade 1-vs-Grade 3 |
3.802500E-03 |
| Grade 1-vs-Grade 4 |
4.762200E-03 |
| Grade 2-vs-Grade 3 |
6.023900E-04 |
| Grade 2-vs-Grade 4 |
1.936610E-01 |
| Grade 3-vs-Grade 4 |
5.970600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.210300E-04 |
| Normal-vs-ccB subtype |
3.06550000050976E-07 |
| ccA subtype-vs-ccB subtype |
8.778300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.72954999999586E-05 |
| Normal-vs-N1 |
3.008200E-04 |
| N0-vs-N1 |
2.731000E-01 |
|
|
